Half Moon Bay, CA, United States of America

Christos J Petropoulos

This inventor holds 21 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Viral Infection Modulation. Top assignees: Monogram Biosciences, Inc., Laboratory Corporation of America Holdings, Virologic, Inc.. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christos J Petropoulos. Retrieved from https://idiyas.com/inventor/christos-j-petropoulos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 4)

% Patents Active = 76.2

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 11 (Patent Applications = 9)

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 151(Granted Patents)

Location History:

South San Francisco, CA (US) (2008)
Half Moon Bay, CA (US) (1998 - 2022)

Company Filing History:

13 out of 52

Monogram Biosciences, Inc.

patents

4 out of 127

Laboratory Corporation of America Holdings

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Coronavirus Infection

Neutralizing Antibodies

Virus Entry Inhibitors

Protease Inhibitors

HIV-1 Susceptibility

Antiviral Drug Screening

Co-Receptor Inhibitors

Viral Receptor Usage

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12724031 - Methods for modulation of coronavirus infection (2026-09-01),

2. 12366581 - Methods, compositions, and systems for detecting coronavirus neutralizing antibodies (2025-07-22),

3. 11459624 - Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays (2022-10-04),

4. 10550441 - Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays (2020-02-04),

5. 10358683 - Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy (2019-07-23),

6. 9841425 - Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays (2017-12-12),

7. 9581595 - Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy (2017-02-28),

8. 9175355 - Methods for determining the presence of antibodies blocking viral infection (2015-11-03),

9. 8603736 - Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays (2013-12-10),

10. 7993824 - Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors (2011-08-09),

11. 7553618 - Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavir (2009-06-30),

12. 7384734 - Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors (2008-06-10),

13. 7279279 - Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening (2007-10-09),

14. 7247439 - Method of evaluating a patient antibody response to envelope proteins of a virus (2007-07-24),

15. 7235356 - Methods of evaluating cell surface receptor binding of a patient derived population of viral envelope protein constructs (2007-06-26),

Title: Christos J. Petropoulos: Innovator in Viral Resistance Research

Introduction

Christos J. Petropoulos is a notable inventor based in Half Moon Bay, CA, with a significant portfolio comprising 19 patents. His work primarily focuses on innovative methods related to viral entry inhibitors, contributing valuable insights to the field of virology.

Latest Patents

Among his latest patents, Christos Petropoulos has developed methods for evaluating resistance to inhibitors of virus entry, particularly concerning human immunodeficiency virus (HIV). His inventions provide methodologies for determining whether an HIV population is resistant to specific viral entry inhibitors. These methods are particularly advantageous for analyzing resistance in cases where inhibitors act by a non-competitive mechanism. By determining a log-sigmoid inhibition curve with data points associated with varying concentrations of the HIV entry inhibitor, this innovative approach helps identify if the entry of the HIV population can be entirely inhibited or not, indicating resistance.

Career Highlights

Throughout his career, Christos has worked with prominent organizations like Monogram Biosciences, Inc. and Virologic, Inc., where he has honed his expertise and conducted extensive research on viral treatments and therapies. His contributions have played a crucial role in advancing our understanding and management of viral infections.

Collaborations

Christos has collaborated with esteemed colleagues such as Neil T. Parkin and Wei Huang. These partnerships have facilitated innovative research efforts and enhanced the quality and impact of their collective work in the field.

Conclusion

Christos J. Petropoulos stands out as a pivotal figure in the study of viral resistance mechanisms. His extensive patent portfolio reflects his commitment to innovation and improving therapeutic options for viral infections. Through his work, Christos continues to make significant strides in virology, helping to guide future research and development in this critical area.

Profile summary based on public USPTO records.